On the other hand, Tyagi et al. (2012) pointed out that pretreatment with silibinin inhibits TNF-α and IFN-γ induced signaling in LM2 cell line (a suitable cell line for studying breast cancer metastasis). The gene discussed is IFNG; the disease is breast carcinoma.